Robert Wade
5 Papers
Robert Wade is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
Stephanie M. de Boer,Melanie E Powell,Linda Mileshkin,Dionyssios Katsaros,Paul Bessette,Christine Haie-Meder,Petronella B. Ottevanger,Jonathan A. Ledermann,Pearly Khaw,Alessandro Colombo,Anthony Fyles,Marie Helene Baron,Ina M. Jürgenliemk-Schulz,Henry C Kitchener,Hans W. Nijman,G. Wilson,Susan Brooks,Silvestro Carinelli,Diane Provencher,Chantal Hanzen,Ludy C.H.W. Lutgens,Vincent T.H.B.M. Smit,Naveena Singh,V. Do,Romerai D'Amico,Remi A. Nout,Amanda Feeney,Karen W Verhoeven-Adema,Hein Putter,Carien L. Creutzberg,Mary McCormack,Karen Whitmarsh,Rozenn Allerton,Deborah Gregory,P. Symonds,Peter Hoskin,Madhavi Adusumalli,Anjana Anand,Robert Wade,Alexandra J. Stewart,Wendy Taylor,Roy F.P.M. Kruitwagen,Harry Hollema,Elizabeth Pras,An Snyers,Lukas J.A. Stalpers,Jan J. Jobsen,Annerie Slot,Jan Willem M. Mens,Tanja C. Stam,Baukelien Van Triest,Elzbieta M. Van der Steen Banasik,Karin A.J. De Winter,Michael A. Quinn,Ilka Kolodziej,Jan Pyman,Carol Johnson,Anne Capp,Roldano Fossati,Sergio Gribaudo,Andrea Lissoni,Annamaria Ferrero,Grazia Artioli,Cathy Davidson,C. Meg McLachlin,Prafull Ghatage,Paula V.C. Rittenberg,Luis Souhami,Gillian Thomas,Pierre Duvillard,Dominique Berton-Rigaud,Nicole Tubiana-Mathieu +71 more
TL;DR: Adjuvant chemotherapy given during and after radiotherapy for high-risk endometrial cancer did not improve 5-year overall survival, although it did increase failure-free survival.
Observation versus screening spinal MRI and pre-emptive treatment for spinal cord compression in patients with castration-resistant prostate cancer and spinal metastases in the UK (PROMPTS): an open-label, randomised, controlled, phase 3 trial
David P. Dearnaley,Victoria Hinder,A. R. Hijab,Gail Horan,Narayanan Srihari,Philip Rich,Jessie Houston,Ann Henry,Stephanie Gibbs,Ramachandran Venkitaraman,Clare Cruickshank,Shama Hassan,Alec Miners,Malcolm David Mason,Ian Pedley,Heather Payne,Susannah Brock,Robert Wade,Angus Robinson,Omar Hossam El Din,Kathryn Lees,John Graham,Jane Worlding,Julia Murray,Chris Parker,Clare Griffin,Aslam Sohaib,Emma Hall +27 more
TL;DR: Routine use of screening MRI and pre-emptive treatment to prevent cSCC is not warranted in patients with asymptomatic castration-resistant prostate cancer with spinal metastasis.
11
O133 Network meta-analysis of neoadjuvant therapy in rectal cancer
Manson Fok,Hayley J. Fowler,R. Clifford,A. Kler,Jamila Gittens,Steven Toh,Robert Wade,Dale Vimalachandran +7 more
TL;DR: In this paper , the authors performed a network meta-analysis to assess which neoadjuvant regime gives the highest rate of pathological complete response (pCR) at surgical resection.
OC-0105 PROMPTS RCT of screening MRI for spinal cord compression in prostate cancer (ISRCTN74112318)
David P. Dearnaley,Victoria Hinder,A. R. Hijab,Gail Horan,Narayanan Srihari,Pamela Sloane Rich,G. V. Houston,Ann Henry,Stephanie Gibbs,Ramachandran Venkitaraman,Clare Cruickshank,Shama Hassan,Matthew Mason,Ian Pedley,Heather Payne,Susannah Brock,Robert Wade,Angus Robinson,O Din,Katherine A. Lees,Julia Murray,C. Parker,C. Griffin,Aslam Sohaib,E. Hall +24 more
Audit of cabozantinib outcomes for metastatic renal cell carcinoma at Norfolk and Norwich University Hospital
Farasat Kazmi,G. Shanmugasundaram,Aravind J Prakash,Olasumbo Taiwo,David Maskell,Robert Wade,Gaurav Kapur +6 more
TL;DR: In this paper , other cancer sites/s ǫ are discussed. ǧ.ǫǫ,ǫ 1.1.1 ǒ 2.